Evidence map›Paper›PMID 38517464›Full record

ArticleJMIR research protocols2024

Telehealth-Delivered Program and Accompanying Patients to Enhance the Clinical Condition of Patients Throughout a Liver Transplant: Protocol for a Mixed Methods Study.

Marie-Pascale Pomey, Enora Le Roux, Nathalie Nadon, Jessie Perron, Angèle Barry, Chantal Bémeur, Thomas G Poder, Fernand Duford, Louise Laviolette, Johanne Tétrault-Lassonde and 9 more

Abstract read
In one paragraph

Article in JMIR research protocols, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Commentary on Vincelette et al.Canadian liver journal · 2025
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Marie-Pascale PomeyCarrefour de l'Innovation, Centre de recherche du Centre hospitalier de l'Université de Montréal, Montréal, QC, Canada.ORCID https://orcid.org/0000-0001-5180-8139
Enora Le RouxCarrefour de l'Innovation, Centre de recherche du Centre hospitalier de l'Université de Montréal, Montréal, QC, Canada.ORCID https://orcid.org/0000-0002-2238-7133
Nathalie NadonCarrefour de l'Innovation, Centre de recherche du Centre hospitalier de l'Université de Montréal, Montréal, QC, Canada.ORCID https://orcid.org/0009-0006-1176-9124
Jessie PerronCarrefour de l'Innovation, Centre de recherche du Centre hospitalier de l'Université de Montréal, Montréal, QC, Canada.ORCID https://orcid.org/0009-0002-7678-9696
Angèle BarryCarrefour de l'Innovation, Centre de recherche du Centre hospitalier de l'Université de Montréal, Montréal, QC, Canada.ORCID https://orcid.org/0000-0003-3680-9437
Chantal BémeurAxe Cardiométabolique, Centre de recherche du Centre hospitalier de l'Université de Montréal, Montreal, QC, Canada.ORCID https://orcid.org/0000-0003-2757-5958
Thomas G PoderDépartement de gestion, évaluation et politique de santé, école de santé publique, Université de Montréal, Montreal, QC, Canada.ORCID https://orcid.org/0000-0001-7017-096X
Fernand DufordDépartement d'hépatologie, Centre hospitalier universitaire de Montréal (CHUM), Montreal, QC, Canada.ORCID https://orcid.org/0009-0006-3604-9457
Louise LavioletteDépartement d'hépatologie, Centre hospitalier universitaire de Montréal (CHUM), Montreal, QC, Canada.ORCID https://orcid.org/0009-0002-8573-3029
Johanne Tétrault-LassondeDépartement d'hépatologie, Centre hospitalier universitaire de Montréal (CHUM), Montreal, QC, Canada.ORCID https://orcid.org/0009-0000-8361-9463
Cécile VialaronCarrefour de l'Innovation, Centre de recherche du Centre hospitalier de l'Université de Montréal, Montréal, QC, Canada.ORCID https://orcid.org/0009-0004-2736-9323
Manuel J EscalonaCarrefour de l'Innovation, Centre de recherche du Centre hospitalier de l'Université de Montréal, Montréal, QC, Canada.ORCID https://orcid.org/0000-0003-2354-9541
Louise NormandinCarrefour de l'Innovation, Centre de recherche du Centre hospitalier de l'Université de Montréal, Montréal, QC, Canada.ORCID https://orcid.org/0000-0002-8166-8090
Geneviève HuardAxe immunopathologie, Centre de recherche du Centre hospitalier de l'Université de Montréal, Montreal, QC, Canada.ORCID https://orcid.org/0009-0000-2591-1351
Catherine GirardinAxe immunopathologie, Centre de recherche du Centre hospitalier de l'Université de Montréal, Montreal, QC, Canada.ORCID https://orcid.org/0009-0006-3738-2083
Christopher RoseAxe Cardiométabolique, Centre de recherche du Centre hospitalier de l'Université de Montréal, Montreal, QC, Canada.ORCID https://orcid.org/0000-0001-9854-6834
Kathy MalasCarrefour de l'Innovation, Centre de recherche du Centre hospitalier de l'Université de Montréal, Montréal, QC, Canada.ORCID https://orcid.org/0000-0001-8419-0507
Denis OuelletDirection de la biovigilance et de la biologie médicale, Ministère de la Santé et des Services sociaux du Québec, Montreal, QC, Canada.ORCID https://orcid.org/0009-0004-1270-2437
Catherine VincentAxe immunopathologie, Centre de recherche du Centre hospitalier de l'Université de Montréal, Montreal, QC, Canada.ORCID https://orcid.org/0000-0001-9711-8010

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLiver transplantation (LT) is indicated in patients with severe acute or chronic liver failure for which no other therapy is available. With the increasing number of LTs in recent years, liver centers worldwide must manage their patients according to their clinical situation and the expected waiting time for transplantation. The LT clinic at the Centre hospitalier de l'Université de Montréal (CHUM) is developing a new health care model across the entire continuum of pre-, peri-, and posttransplant care that features patient monitoring by an interdisciplinary team, including an accompanying patient; a digital platform to host a clinical plan; a learning program; and data collection from connected objects.

objectiveThis study aims to (1) evaluate the outcomes following the implementation of a patient platform with connected devices and an accompanying patient, (2) identify implementation barriers and facilitators, (3) describe service outcomes in terms of health outcomes and the rates and nature of contact with the accompanying patient, (4) describe patient outcomes, and (5) assess the intervention's cost-effectiveness.

methodsSix types of participants will be included in the study: (1) patients who received transplants and reached 1 year after transplantation before September 2023 (historical cohort or control group), (2) patients who will receive an LT between December 2023 and November 2024 (prospective cohort/intervention group), (3) relatives of those patients, (4) accompanying patients who have received an LT and are interested in supporting patients who will receive an LT, (5) health care professionals, and (6) decision makers. To describe the study sample and collect data to achieve all the objectives, a series of validated questionnaires, accompanying patient logbooks, transcripts of interviews and focus groups, and clinical indicators will be collected throughout the study.

resultsIn total, 5 (steering, education, clinical-technological, nurse prescription, and accompanying patient) working committees have been established for the study. Recruitment of patients is expected to start in November 2023. All questionnaires and technological platforms have been prepared, and the clinicians, stakeholders, and accompanying patient personnel have been recruited.

conclusionsThe implementation of this model in the trajectory of LT recipients at the CHUM may allow for better monitoring and health of patients undergoing transplantation, ultimately reducing the average length of hospital stay and promoting better use of medical resources. In the event of positive results, this model could be transposed to all transplant units at the CHUM and across Quebec (potentially affecting 888 patients per year) but could also be applied more widely to the monitoring of patients with other chronic diseases. The lessons learned from this project will be shared with decision makers and will serve as a model for other initiatives involving accompanying patients, connected objects, or digital platforms. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): PRR1-10.2196/54440.

Indexed as

accompanying patientsconnected objectsdigital platformhealth care modelliver transplantation

Identifiers

PMID38517464
PMCPMC10998179

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.